Yayınlar & Eserler

Yayın Ağı

SCI, SSCI ve AHCI İndekslerine Giren Dergilerde Yayınlanan Makaleler

Combining Endocrine Therapy with Trastuzumab Emtansine Improves Progression-Free Survival and Overall Survival in HER2-Positive, Hormone Receptor-Positive Metastatic Breast Cancer

Kınıkoğlu O., Odabas H., Altıntaş Y. E., YILDIZ A., Çakan B., Akdağ G., et al.
Medicina (Kaunas, Lithuania) , cilt.60, sa.6, 2024 (SCI-Expanded) Creative Commons License identifier identifier identifier

Therapeutic efficacy of high-dose chemotherapy with autologous stem-cell transplantation in 44 relapsed or refractory germ-cell tumor patients: A retrospective cohort study

Ferhatoglu F., Paksoy N., Khanmammadov N., YILDIZ A., AHMED M. A., Gülbas Z., et al.
Medicine , cilt.103, sa.8, 2024 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier

The effect of parity, breastfeeding history, and duration on clinical and pathological characteristics of breast cancer patients

Ak N., Tuz Z., Aydin E., Ferhatoğlu F., SARI M., Paksoy N., et al.
Turkish Journal of Medical Sciences , cilt.54, sa.1, ss.229-238, 2024 (SCI-Expanded) Creative Commons License identifier

Comparison of the efficacy of sunitinib and pazopanib in patients with advanced non-clear renal cell carcinoma

Yildirim H. C., BAYRAM E., Chalabiyev E., Majidova N., Avci T., Güzel H. G., et al.
Journal of Chemotherapy , 2024 (SCI-Expanded) identifier identifier identifier

Toxicity management and efficacy of carboplatin desensitization therapy for recurrent epithelial ovarian carcinoma: A real-world study

PAKSOY N., KHANMAMMADOV N., DOĞAN İ., FERHATOĞLU F., YILDIZ A., AK N., et al.
Medicine (United States) , cilt.101, sa.45, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier

Diğer Dergilerde Yayınlanan Makaleler

Efficacy of Lapatinib Plus Capecitabine After TDM-1 in HER2-Positive Metastatic Breast Cancer Patients

Dogan I., Yıldız A., Ahmed M. A., Vatansever S.
Indian Journal of Surgical Oncology , cilt.15, sa.3, ss.489-494, 2024 (ESCI) identifier

Efficacy of Intrathecal Therapy In Breast Cancer Patients With Leptomeningeal Metastasis

Khanmammadov N., Dogan I., AHMED M. A., YILDIZ A., Nizam N., KHISHIGSUREN B., et al.
Eastern Journal of Medicine , cilt.29, sa.4, ss.503-508, 2024 (Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier

Evaluation of the Efficacy of Bevacizumab-based Therapies in Patients with Platinum-Resistant or-Allergic Metastatic Ovarian Cancer

Khanmammadov N., Doğan İ., Okay N. S., YILDIZ A., Khishigsuren B., AZİZY A., et al.
Turk Onkoloji Dergisi , cilt.39, sa.2, ss.176-182, 2024 (ESCI) Sürdürülebilir Kalkınma identifier identifier

Kan Plazmasında Satellit-2 Tekrar Elementi DNA Dizilerinin Karakterizasyonu

ÖZGÜR E., YILDIZ A., BADEMLER S., GEZER U.
İstanbul Gelişim Üniversitesi Sağlık Bilimleri Dergisi , 2022 (Hakemli Dergi)

Outcomes and Prognostic Factors in Patients with EGFR Mutant Metastatic Non-Small Cell Lung Cancer Who Treated with Erlotinib

DOĞAN İ., Khanmammadov N., Ahmed M. A., Yildiz A., Saip P., Aydiner A., et al.
CLINICAL CANCER INVESTIGATION JOURNAL , sa.4, ss.5-9, 2022 (ESCI) Creative Commons License Sürdürülebilir Kalkınma identifier

Crizotinib in Metastatic ALK mutant Non-small Cell Lung Cancer Patients: A Single Centre Experience

DOĞAN İ., Khanmammadov N., Ahmed M. A., Yildiz A., Saip P., Aydiner A., et al.
CLINICAL CANCER INVESTIGATION JOURNAL , sa.3, ss.25-29, 2022 (ESCI) Creative Commons License Sürdürülebilir Kalkınma identifier

Metrikler

Yayın

11

Atıf (WoS)

1

H-İndeks (WoS)

1

Atıf (Scopus)

4

H-İndeks (Scopus)

1

Açık Erişim

5
BM Sürdürülebilir Kalkınma Amaçları